The antisense and rnai therapeutics market size has the potential to grow by $ 1.61 bn during 2021-2025, and the market’s growth momentum will accelerate during the forecast period.
This report provides a detailed analysis of the market by type (antisense therapy and RNAi therapy), geography (North America, Europe, Asia, and ROW), and application (infectious diseases, cardiovascular diseases, cancer, metabolic disorder, and others). Also, the report analyzes the market’s competitive landscape and offers information on several market vendors, including Alnylam Pharmaceuticals Inc., Arrowhead Pharmaceuticals Inc., Bausch Health Companies Inc., Biogen Inc., Boehringer Ingelheim International GmbH, Dicerna Pharmaceuticals Inc., Ionis Pharmaceuticals Inc., Moderna Inc., Sanofi, and Sarepta Therapeutics Inc..
Market Overview
Browse TOC and LoE with selected illustrations and example pages of Antisense and RNAi Therapeutics Market
Market Competitive Analysis
The antisense and rnai therapeutics market is concentrated. Alnylam Pharmaceuticals Inc., Arrowhead Pharmaceuticals Inc., Bausch Health Companies Inc., Biogen Inc., Boehringer Ingelheim International GmbH, Dicerna Pharmaceuticals Inc., Ionis Pharmaceuticals Inc., Moderna Inc., Sanofi, and Sarepta Therapeutics Inc. are some of the major market participants. Factors such as high target affinity and specificity of rnai therapeutics will offer immense growth opportunities. However, high price of rnai drugs may impede market growth. To make the most of the opportunities, vendors should focus on growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
To help clients improve their market position, this antisense and rnai therapeutics market forecast report provides a detailed analysis of the market leaders and offers information on the competencies and capacities of these companies. The report also covers details on the market’s competitive landscape and offers information on the products offered by various companies. Moreover, this antisense and rnai therapeutics market analysis report provides information on the upcoming trends and challenges that will influence market growth. This will help companies create strategies to make the most of future growth opportunities.
This report provides information on the production, sustainability, and prospects of several leading companies, including:
- Alnylam Pharmaceuticals Inc.
- Arrowhead Pharmaceuticals Inc.
- Bausch Health Companies Inc.
- Biogen Inc.
- Boehringer Ingelheim International GmbH
- Dicerna Pharmaceuticals Inc.
- Ionis Pharmaceuticals Inc.
- Moderna Inc.
- Sanofi
- Sarepta Therapeutics Inc.
|
Antisense And RNAi Therapeutics Market Scope |
|
|
Report Coverage |
Details |
|
Page number |
120 |
|
Base year |
2020 |
|
Forecast period |
2021-2025 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 8% |
|
Market growth 2021-2025 |
$ 1.61 billion |
|
Market structure |
Concentrated |
|
YoY growth (%) |
8.00 |
|
Regional analysis |
North America, Europe, Asia, and ROW |
|
Performing market contribution |
North America at 53% |
|
Key consumer countries |
US, Canada, UK, France, and China |
|
Competitive landscape |
Leading companies, competitive strategies, consumer engagement scope |
|
Companies profiled |
Alnylam Pharmaceuticals Inc., Arrowhead Pharmaceuticals Inc., Bausch Health Companies Inc., Biogen Inc., Boehringer Ingelheim International GmbH, Dicerna Pharmaceuticals Inc., Ionis Pharmaceuticals Inc., Moderna Inc., Sanofi, and Sarepta Therapeutics Inc. |
|
Market Dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and future consumer dynamics, market condition analysis for forecast period, |
|
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
Antisense and RNAi Therapeutics Market: Segmentation by Geography
For more insights on the market share of various regions Request for a FREE sample now!
The report offers an up-to-date analysis regarding the current Global market scenario, latest trends and drivers, and the overall market environment. North America will offer several growth opportunities to market vendors during the forecast period. The ease of standardization and large-scale manufacturing will significantly influence antisense and rnai therapeutics market's growth in this region.
53% of the market’s growth will originate from North America during the forecast period. US | Canada | UK | France | China are the key markets for antisense and rnai therapeutics market in North America. This report provides an accurate prediction of the contribution of all segments to the growth of the antisense and rnai therapeutics market size.
Antisense and RNAi Therapeutics Market: Key Highlights of the Report for 2021-2025
- CAGR of the market during the forecast period 2021-2025
- Detailed information on factors that will drive antisense and rnai therapeutics market growth during the next five years
- Precise estimation of the antisense and rnai therapeutics market size and its contribution to the parent market
- Accurate predictions on upcoming trends and changes in consumer behavior
- The growth of the antisense and rnai therapeutics market industry across North America, Europe, Asia, and ROW
- A thorough analysis of the market’s competitive landscape and detailed information on vendors
- Comprehensive details of factors that will challenge the growth of antisense and rnai therapeutics market vendors
We can help! Our analysts can customize this report to meet your requirements. Get in touch